2019
DOI: 10.1002/wnan.1596
|View full text |Cite
|
Sign up to set email alerts
|

Recent advancements in two‐dimensional nanomaterials for drug delivery

Abstract: Different from conventional zero‐dimensional (0D) and one‐dimensional (1D) counterparts, two‐dimensional (2D) nanomaterials show unique properties resulting from their specific structure and morphology. In recent years, broad interest has been focused on the exploration of 2D nanomaterials for drug delivery, which benefits greatly to various disease treatments due to the superior properties of 2D nanomaterials. The fast development of 2D‐based drug delivery systems provides great potential for biomedical studi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
27
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(27 citation statements)
references
References 159 publications
(280 reference statements)
0
27
0
Order By: Relevance
“…Understanding the interactions between nanomaterials and biological systems, in particular cellular membranes, is fundamental to address important challenges such as the safe design and regulation of novel engineered nanomaterials, [ 1–3 ] development of drug delivery systems, [ 4,5 ] and membrane active nanomedicines. [ 6,7 ] Nanomaterials may interact with plasma membranes prior to cellular uptake [ 8–12 ] and with membranes of intracellular vesicles following uptake.…”
Section: Introductionmentioning
confidence: 99%
“…Understanding the interactions between nanomaterials and biological systems, in particular cellular membranes, is fundamental to address important challenges such as the safe design and regulation of novel engineered nanomaterials, [ 1–3 ] development of drug delivery systems, [ 4,5 ] and membrane active nanomedicines. [ 6,7 ] Nanomaterials may interact with plasma membranes prior to cellular uptake [ 8–12 ] and with membranes of intracellular vesicles following uptake.…”
Section: Introductionmentioning
confidence: 99%
“…[131][132][133][134][135][136][137] However, compared with bulk LDH, monolayer LDH (MLDH) nanosheets exhibit much higher specic surface and more combinative sites, leading to greatly enhanced surface activity for drug loading. [138][139][140][141][142][143][144][145][146][147] For example, MgAl-LDH monolayer nanosheets were employed to localize doxorubicin (DOX), 148 the DOX/MLDH showed extremely high loading efficiency (3.6 mg mg À1 (w/w)) and controllable release behavior. XRD, AFM, and HRTEM conrmed the successful preparation of the MLDH nanosheets (Fig.…”
Section: Drug Delivery Hostsmentioning
confidence: 99%
“…The purpose of using hydrazine is to reduce silver ions to the silver metal, which is then conjugated to gold nanoparticles. A bioconjugate of hydrazine−AuNP−aptamer (Hyd−AuNP−Apt) was synthesized and reported [57]. The analysis of the silver deposited was done by square wave stripping voltammetry to determine the number of cancer cells.…”
Section: Swcnts Functionalized With Gnpop For Targeted Diagnosis Of Breast Cancermentioning
confidence: 99%
“…Tungsten disulfide WS 2 is a graphene-like layered material with a high drug loading capacity due to its large specific area [57]. WS 2 nanosheet is beneficial for various reasons, such as the presence of many active sites on its surface that can be used for surface modification.…”
Section: Biomimetic Lipid-modified Ws 2 Nanosheets For Breast Cancer Therapymentioning
confidence: 99%